RCR rincon resources limited

0.00%

1.2¢

The Greeks still believe they will get bailed out by the EU, on...

First 31 Last

Share
Profile

Follow
Hotfire

19,936 Posts.

330

06/07/15

20:24

Post #: 15589350
Share

Originally posted by Downanout ↑

Perhaps your bitching to the company prompted some action or maybe it was just that the SP had reached their uncle price.

Baring more sinister motivations for the buyback, it looks like management thinks its shares were worth at least $1.72 on Friday. We can only hope they have some idea. However, the average buyback price prior to Friday was $2.247, so maybe they are just guessing like the rest of us. They can buy mine for $2.247!!!

What a lousy day. My portfolio certainly isn't Greeceproof.
I am looking at a sea of red except for NST, EZL, PME and LGD.
Considering that the Greeks would be laughing if they were relieved of $200 billion in debt, that pales into insignificance compared to the amount wiped of world market caps since last Monday, which is more like $2000 billion plus. That suggests that either Mr Market is attaching a significance to the Greek situation, which goes way way beyond the debt, or else he is worried about something else as well.

Expand

The Greeks still believe they will get bailed out by the EU, on more desirable terms, even with their referrundum NO vote.

Oddly enough I think that may just be the case.

Why hasn't gold rocketed on this so called euro crises?

Meanwhile RCR may be giving us a clue that revenue and profit is out performing what the market thinks. As it would be a little irresponsible to resume the buy back if there when material doubts about revenue and profit.

RCR Price at posting: $1.64 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 31 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.2¢		Change 0.000(0.00%)		Mkt cap ! $3.510M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.2¢	$9.738K	811.5K

Buyers (Bids)

No.	Vol.	Price($)
8	2991811	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	32500	1

View Market Depth

No.	Vol.	Price($)
8	2991811	0.011
4	1622323	0.010
4	402222	0.009
3	480000	0.008
2	271430	0.007

Price($)	Vol.	No.
0.012	32500	1
0.013	772000	2
0.014	1326174	5
0.016	276029	2
0.019	35117	1

Last trade - 14.57pm 27/06/2025 (20 minute delay)

RCR (ASX) Chart

The Greeks still believe they will get bailed out by the EU, on...

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The Greeks still believe they will get bailed out by the EU, on...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News